ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

Russia registers world's first COVID vaccine for animals: watchdog

Carnivac-Cov jabs developed by a unit of Rosselkhoznadzor

The vaccine for animals, developed by a unit of Russian agricultural safety watchdog Rosselkhoznadzor, produced coronavirus antibodies in 100% of the animals vaccinated, it said.   © Reuters

MOSCOW (Reuters) -- Russia has registered the world's first vaccine against COVID-19 for animals, the country's agriculture safety watchdog Rosselkhoznadzor said on Wednesday.

Russia already has three coronavirus vaccines for humans, the most well known of which is Sputnik V. Moscow has also given emergency approval to two others, EpiVacCorona and CoviVac.

The vaccine for animals, developed by a unit of Rosselkhoznadzor, was named Carnivac-Cov, the watchdog said.

"The clinical trials of Carnivac-Cov, which started last October, involved dogs, cats, Arctic foxes, minks, foxes and other animals," said Rosselkhoznadzor's Deputy Head Konstantin Savenkov.

"The results of the trials allow us to conclude that the vaccine is harmless and highly immunogenic as all the vaccinated animals developed antibodies to the coronavirus in 100% of cases."

Immunity lasts for six months after vaccination, but the shot's developers are continuing to analyse this, the watchdog said.

Mass production of the vaccine could start as early as April, Rosselkhoznadzor added.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more